Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:2864-2868
Published online before print October 25, 2004, doi: 10.1161/01.CIR.0000146336.92331.D1
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/18/2864    most recent
01.CIR.0000146336.92331.D1v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abraham, W. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abraham, W. T.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Congestive
Right arrow Pacemaker
Right arrow Exercise testing
Right arrow Echocardiography

(Circulation. 2004;110:2864-2868.)
© 2004 American Heart Association, Inc.


Heart Failure

Effects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defibrillator, and Mildly Symptomatic Chronic Heart Failure

William T. Abraham, MD; James B. Young, MD; Angel R. León, MD; Stuart Adler, MD; Alan J. Bank, MD; Shelley A. Hall, MD; Randy Lieberman, MD; L. Bing Liem, DO; John B. O’Connell, MD; John S. Schroeder, MD; Kevin R. Wheelan, MD, on behalf of the Multicenter InSync ICD II Study Group

From the Ohio State University Heart Center, Columbus (W.T.A.); Cleveland Clinic Foundation, Cleveland, Ohio (J.B.Y.); Emory University-Crawford Long Hospital, Atlanta, Ga (A.R.L.); St Paul Heart Clinic, St Paul, Minn (A.J.B., S.A.); Baylor Heart and Vascular Hospital, Dallas, Tex (S.A.H., K.R.W.); Harper University Hospital-Wayne State University, Detroit, Mich (J.B.O., R.L.); and Stanford University, Palo Alto, Calif (L.B.L., J.S.S.).

Correspondence to William T. Abraham, MD, Ohio State University Heart Center, Division of Cardiovascular Medicine, 473 W 12th Ave, Room 110P DHLRI, Columbus, OH 43210-1252. E-mail abraham-1{at}medctr.osu.edu

Received February 11, 2004; de novo received June 6, 2004; accepted July 21, 2004.

Background— The effects of cardiac resynchronization therapy (CRT) in patients with mildly symptomatic heart failure have not been fully elucidated.

Methods and Results— The Multicenter InSync ICD Randomized Clinical Evaluation II (MIRACLE ICD II) was a randomized, double-blind, parallel-controlled clinical trial of CRT in NYHA class II heart failure patients on optimal medical therapy with a left ventricular (LV) ejection fraction ≤35%, a QRS ≥130 ms, and a class I indication for an ICD. One hundred eighty-six patients were randomized: 101 to the control group (ICD activated, CRT off) and 85 to the CRT group (ICD activated, CRT on). End points included peak VO2, VE/VCO2, NYHA class, quality of life, 6-minute walk distance, LV volumes and ejection fraction, and composite clinical response. Compared with the control group at 6 months, no significant improvement was noted in peak VO2, yet there were significant improvements in ventricular remodeling indexes, specifically LV diastolic and systolic volumes (P=0.04 and P=0.01, respectively), and LV ejection fraction (P=0.02). CRT patients showed statistically significant improvement in VE/VCO2 (P=0.01), NYHA class (P=0.05), and clinical composite response (P=0.01). No significant differences were noted in 6-minute walk distance or quality of life scores.

Conclusions— In patients with mild heart failure symptoms on optimal medical therapy with a wide QRS complex and an ICD indication, CRT did not alter exercise capacity but did result in significant improvement in cardiac structure and function and composite clinical response over 6 months.


Key Words: defibrillators, implantable • exercise test • heart failure • pacing • ventricular remodeling




This article has been cited by other articles:


Home page
HeartHome page
M Marciniak, B Bijnens, A Baltabaeva, A Marciniak, C Parsai, P Claus, and G R Sutherland
Interventricular interaction as a possible mechanism for the presence of a biphasic systolic velocity profile in normal left ventricular free walls
Heart, August 1, 2008; 94(8): 1058 - 1064.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. H. Manisty, K. Willson, J. E. R. Davies, Z. I. Whinnett, R. Baruah, Y. Mebrate, P. Kanagaratnam, N. S. Peters, A. D. Hughes, J. Mayet, et al.
Induction of oscillatory ventilation pattern using dynamic modulation of heart rate through a pacemaker
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R219 - R227.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. Daubert, C. Leclercq, H. Miljoen, B. P. Paelinck, C. J. Vrints, J. F. Beshai, R. A. Grimm, and S. F. Nagueh
Cardiac-Resynchronization Therapy
N. Engl. J. Med., April 24, 2008; 358(17): 1865 - 1866.
[Full Text] [PDF]


Home page
HeartHome page
J G F Cleland, N Freemantle, J-C Daubert, W D Toff, F Leisch, and L Tavazzi
Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study
Heart, March 1, 2008; 94(3): 278 - 283.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. T. Klodell Jr, J. M. Aranda Jr, D. C. McGiffin, B. K. Rayburn, B. Sun, W. T. Abraham, W. E. Pae Jr, J. P. Boehmer, H. Klein, and C. Huth
Worldwide surgical experience with the Paracor HeartNet cardiac restraint device
J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 188 - 195.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. M. Kavanagh, I. Belenkie, and H. J. Duff
Transmural temporospatial left ventricular activation during pacing from different sites: potential implications for optimal pacing
Cardiovasc Res, January 1, 2008; 77(1): 81 - 88.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
C. Leclercq, G. B. Bleeker, C. Linde, E. Donal, J. J. Bax, M. J. Schalij, and C. Daubert
Cardiac resynchronization therapy: clinical results and evolution of candidate selection
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I94 - I106.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. W. Kimmel, N. D. Skadsberg, C. L. Byrd, D. J. Wright, T. G. Laske, and P. A. Iaizzo
Single-site ventricular and biventricular pacing: investigation of latest depolarization strategy
Europace, December 1, 2007; 9(12): 1163 - 1170.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Europace, October 1, 2007; 9(10): 959 - 998.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295.
[Full Text] [PDF]


Home page
HeartHome page
C Leclercq
New guidelines for cardiac resynchronisation therapy: simplicity or complexity for the doctor?
Heart, September 1, 2007; 93(9): 1017 - 1019.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
S. H. Hohnloser and E. N. Prystowsky
CRT-D use in heart failure: too little or too much?
Eur. Heart J. Suppl., September 1, 2007; 9(suppl_G): G9 - G16.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
F. A. McAlister, J. Ezekowitz, N. Hooton, B. Vandermeer, C. Spooner, D. M. Dryden, R. L. Page, M. A. Hlatky, and B. H. Rowe
Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction: A Systematic Review
JAMA, June 13, 2007; 297(22): 2502 - 2514.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. D. Burkhardt and B. L. Wilkoff
Interventional Electrophysiology and Cardiac Resynchronization Therapy: Delivering Electrical Therapies for Heart Failure
Circulation, April 24, 2007; 115(16): 2208 - 2220.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. K. Rao, U. N. Kumar, J. Schafer, E. Viloria, D. De Lurgio, and E. Foster
Reduced Ventricular Volumes and Improved Systolic Function With Cardiac Resynchronization Therapy: A Randomized Trial Comparing Simultaneous Biventricular Pacing, Sequential Biventricular Pacing, and Left Ventricular Pacing
Circulation, April 24, 2007; 115(16): 2136 - 2144.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. T. Klodell Jr, D. C. McGiffin, B. K. Rayburn, B. Sun, W. T. Abraham, J. V. Conte, S. D. Russell, W. E. Pae Jr, J. P. Boehmer, and J. M. Aranda Jr
Initial United States experience with the Paracor HeartNet myocardial constraint device for heart failure
J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 204 - 209.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Greenberg and M. R. Mehra
All Patients With Heart Failure and Intraventricular Conduction Defect or Dyssynchrony Should Not Receive Cardiac Resynchronization Therapy
Circulation, December 12, 2006; 114(24): 2685 - 2691.
[Full Text] [PDF]


Home page
CirculationHome page
W. T. Abraham
Response to Abraham
Circulation, December 12, 2006; 114(24): 2692 - 2698.
[Full Text] [PDF]


Home page
NEJMHome page
J. A. Jarcho
Biventricular pacing.
N. Engl. J. Med., July 20, 2006; 355(3): 288 - 294.
[Full Text] [PDF]


Home page
Eur Heart JHome page
N. M. Hawkins, M. C. Petrie, M. R. MacDonald, K. J. Hogg, and J. J.V. McMurray
Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?
Eur. Heart J., June 1, 2006; 27(11): 1270 - 1281.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. Donal, C. Leclercq, C. Linde, and J.-C. Daubert
Effects of cardiac resynchronization therapy on disease progression in chronic heart failure
Eur. Heart J., May 1, 2006; 27(9): 1018 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Saleh, O. J. Liakopoulos, and G. D. Buckberg
The septal motor of biventricular function
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(Suppl_1): S126 - S138.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Tomioka, O. J. Liakopoulos, G. D. Buckberg, N. Hristov, Z. Tan, and G. Trummer
The effect of ventricular sequential contraction on helical heart during pacing: high septal pacing versus biventricular pacing
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(Suppl_1): S198 - S206.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. J. Bax, T. Abraham, S. S. Barold, O. A. Breithardt, J. W.H. Fung, S. Garrigue, J. Gorcsan III, D. L. Hayes, D. A. Kass, J. Knuuti, et al.
Cardiac Resynchronization Therapy: Part 2--Issues During and After Device Implantation and Unresolved Questions
J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2168 - 2182.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. C. Daubert, C. Leclercq, and P. Mabo
There Is Plenty of Room for Cardiac Resynchronization Therapy Devices Without Back-Up Defibrillators in the Electrical Treatment of Heart Failure
J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2204 - 2207.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. A. Hlatky
Cost Effectiveness of Cardiac Resynchronization Therapy
J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2322 - 2324.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Carson, I. Anand, C. O'Connor, B. Jaski, J. Steinberg, A. Lwin, J. Lindenfeld, J. Ghali, J. H. Barnet, A. M. Feldman, et al.
Mode of Death in Advanced Heart Failure: The Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) Trial
J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2329 - 2334.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Kadish and M. Mehra
Heart Failure Devices: Implantable Cardioverter-Defibrillators and Biventricular Pacing Therapy
Circulation, June 21, 2005; 111(24): 3327 - 3335.
[Full Text] [PDF]


Home page
CirculationHome page
S. A. Strickberger, J. Conti, E. G. Daoud, E. Havranek, M. R. Mehra, I. L. Pina, J. Young, and Endorsed by the American College of Cardiology Fou
Patient Selection for Cardiac Resynchronization Therapy: From the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Heart Rhythm Society
Circulation, April 26, 2005; 111(16): 2146 - 2150.
[Abstract] [Full Text] [PDF]